State Board Of Administration Of Florida Retirement System Allakos Inc. Transaction History

State Board Of Administration Of Florida Retirement System

$51.5 Billion
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$1.72 - $3.18 $29,706 - $54,921	17,271 New	17,271 $47,000
Q2 2023 Aug 11, 2023	BUY	$3.6 - $5.25 $67,932 - $99,067	18,870 New	18,870 $82,000
Q2 2022 Aug 05, 2022	SELL	$2.6 - $6.14 $35,222 - $83,178	-13,547 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$76.53 - $110.43 $39,030 - $56,319	510 Added 3.91%	13,547 $1.43 Million
Q2 2021 Aug 10, 2021	BUY	$85.37 - $114.1 $254,487 - $340,132	2,981 Added 29.64%	13,037 $1.11 Million
Q1 2021 May 10, 2021	BUY	$109.73 - $153.66 $60,351 - $84,513	550 Added 5.79%	10,056 $1.15 Million
Q4 2020 Feb 08, 2021	SELL	$79.58 - $152.45 $7,958 - $15,244	-100 Reduced 1.04%	9,506 $1.33 Million
Q3 2020 Nov 09, 2020	BUY	$66.43 - $90.99 $41,186 - $56,413	620 Added 6.9%	9,606 $782,000
Q2 2020 Aug 07, 2020	BUY	$44.04 - $80.69 $81,429 - $149,195	1,849 Added 25.91%	8,986 $646,000
Q4 2019 Feb 03, 2020	BUY	$66.49 - $137.73 $43,883 - $90,901	660 Added 10.19%	7,137 $681,000
Q2 2019 Aug 05, 2019	BUY	$36.0 - $44.73 $233,172 - $289,716	6,477 New	6,477 $281,000

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

Bvf Inc San Francisco, CA

16.6M
Shares

$17.5 Million
0.34% of portfolio
Nea Management Company, LLC Timonium, MD

6.15M
Shares

$6.52 Million
0.31% of portfolio
Deep Track Capital, LP Greenwich, CT

5M
Shares

$5.3 Million
0.12% of portfolio
Vanguard Group Inc Valley Forge, PA

3.51M
Shares

$3.73 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

3.08M
Shares

$3.26 Million
0.13% of portfolio

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $89.8M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.

Account